Log In
BCIQ
Print this Print this
 

AZD4635, HTL1071

  Manage Alerts
Collapse Summary General Information
Company Sosei Group Corp.
DescriptionSmall molecule adenosine A2A receptor (ADORA2A) inhibitor
Molecular Target Adenosine A2A receptor (ADORA2A)
Mechanism of ActionAdenosine A2A receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid malignancies
Regulatory Designation
PartnerAstraZeneca plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$510.0M

0

0


 Deals Details
Get a free BioCentury trial today